No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17365678 |
chr2:11055298-11055299 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs543476576 |
chr2:11055323-11055324 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs12623956 |
chr2:11055328-11055329 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs529220742 |
chr2:11055383-11055384 |
Active TSS Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs547575045 |
chr2:11055446-11055447 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs559287285 |
chr2:11055471-11055472 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs533203721 |
chr2:11055507-11055508 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs2123483 |
chr2:11055557-11055558 |
Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs570168531 |
chr2:11055611-11055612 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs537028222 |
chr2:11055625-11055626 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs59786077 |
chr2:11055636-11055637 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs184800408 |
chr2:11055637-11055638 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs148058253 |
chr2:11055645-11055646 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs61193809 |
chr2:11055652-11055653 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs553100942 |
chr2:11055670-11055671 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs578108178 |
chr2:11055687-11055688 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs73184560 |
chr2:11055728-11055729 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs141812454 |
chr2:11055783-11055784 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs535399783 |
chr2:11055798-11055799 |
Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs372244469 |
chr2:11055837-11055838 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs60600332 |
chr2:11055838-11055839 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs561676838 |
chr2:11055852-11055853 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs188627888 |
chr2:11055853-11055854 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs58555121 |
chr2:11055878-11055879 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs113576857 |
chr2:11055907-11055908 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs559643098 |
chr2:11055930-11055931 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs146031473 |
chr2:11055942-11055943 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs551582754 |
chr2:11055963-11055964 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs576163385 |
chr2:11056004-11056005 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs373093756 |
chr2:11056024-11056025 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs530925530 |
chr2:11056092-11056093 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs115007096 |
chr2:11056093-11056094 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs551895963 |
chr2:11056128-11056129 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs555744741 |
chr2:11056155-11056156 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs112930156 |
chr2:11056177-11056178 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs78982529 |
chr2:11056183-11056184 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs546967843 |
chr2:11056268-11056269 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs191941846 |
chr2:11056276-11056277 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs573403831 |
chr2:11056282-11056283 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538834683 |
chr2:11056284-11056285 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs557546925 |
chr2:11056310-11056311 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs576015589 |
chr2:11056315-11056316 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs537146851 |
chr2:11056348-11056349 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs555548872 |
chr2:11056377-11056378 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs573672622 |
chr2:11056394-11056395 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs541065513 |
chr2:11056419-11056420 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs184369529 |
chr2:11056425-11056426 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs140004820 |
chr2:11056505-11056506 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs544839126 |
chr2:11056509-11056510 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs563506081 |
chr2:11056571-11056572 |
Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|